CVE-2026-5663OFFIS DCMTK storescp storescp.cc executeOnEndOfStudy os command injection
Updated under an hour ago ()
Does this affect you?
It affects OFFIS DCMTK. Add what you run to find out whether that includes you.
EPSS puts the chance of exploitation in the next 30 days at 2.83%, higher than 86% of scored CVEs.
Do this next
Free account, 1 product
A security flaw has been discovered in OFFIS DCMTK up to 3.7.0. This impacts the function executeOnReception/executeOnEndOfStudy of the file dcmnet/apps/storescp.cc of the component storescp. Performing a manipulation results in os command injection. Remote exploitation of the attack is possible. The patch is named edbb085e45788dccaf0e64d71534cfca925784b8. Applying a patch is the recommended action to fix this issue.
- CVSS
- 7.3 HIGH (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L/E:X/RL:O/RC:C
- Weakness (CWE)
- CWE-78, CWE-77
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- 2.83% (percentile 86)
- Assigned by
- VulDB
- NVD analysis
- Analyzed
- Record last updated
- Apr 7, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
OFFIS DCMTK offis:dcmtk | 3.0; 3.1; 3.2; 3.3; 3.4; 3.5; 3.6; 3.7.0 | CNA record |
offis dcmtk offis:dcmtk | through 3.7.0 | NVD |
References
- https://vuldb.com/vuln/355486vdb-entry, technical-description, third-party-advisory
- https://vuldb.com/vuln/355486/ctisignature, permissions-required, vdb-entry
- https://vuldb.com/submit/786061third-party-advisory, vdb-entry
- https://machinespirits.com/advisory/2e1627/related, mitigation, third-party-advisory
- https://support.dcmtk.org/redmine/issues/1194issue-tracking, third-party-advisory
- https://github.com/DCMTK/dcmtk/commit/edbb085e45788dccaf0e64d71534cfca925784b8patch
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.